Hypoglycemia syndrome: features of differential diagnostics

Diagnosis and differential diagnosis of hypoglycemia syndrome may present some difficulties for general practitioners. Clinical manifestations of hypoglycemia are weakness, tachycardia, tremor, sweating, impaired consciousness up to coma. Symptoms of hypoglycemic conditions at the beginning of their development are often nonspecific, the severity of their manifestations is lost with frequent recurrence. It is important to note that hypoglycemia is a life-threatening condition requiring treatment. Hypoglycemia can be caused by taking hypoglycemic drugs, exacerbation of chronic adrenal insufficiency, or increased secretion of insulin by a tumor – insulinoma. Iatrogenic hypoglycemia in patients with diabetes mellitus is recognized by patients quite quickly, since patients regularly monitor glycemic levels. Hypoglycemia in adrenal insufficiency usually occurs in the early morning hours. In insulinoma, hypoglycemia may develop at any time of the day, since it is associated with spontaneous or provoked secretion of large amounts of insulin by the tumor. The size of the insulinoma may be small, which complicates confirmation of the diagnosis by visualization. Also, insulinoma may occur as one of the manifestations of the syndrome of multiple endocrine neoplasia – in this case, it is necessary to assess the function of the parathyroid glands and pituitary gland. The article presents a clinical case of multiple recurrent insulinoma in a young patient. This clinical observation is of particular interest, since it presents the process of primary diagnostics of insulinoma, as well as postoperative dynamic observation of the patient, during which a relapse of the neoplasm was detected. As part of the preoperative preparation, therapy with short-acting somatostatin analogues was prescribed, after which repeated surgical treatment was performed.

1. Дедов ИИ, Мельниченко ГА (ред.). Эндокринология: национальное руководство. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа; 2022. 1112 с. Режим доступа: https://www.rosmedlib.ru/book/ISBN9785970467510.html.

2. Krivko AA, Melnichenko GA, Kuznetsov NS, Troshina EA, Dedov II. Modern technologies in diagnostics and treatment of insulinoma. Problemy Endokrinologii. 2013;(5):36–41. (In Russ.) Available at: https://www.mediasphera.ru/issues/problemy-endokrinologii/2013/5/downloads/ru/030375-9660201356.

3. Yukina MY, Nuralieva NF, Troshina EA, Kuznetsov NS, Platonova NM. The hypoglycemic syndrome (insulinoma): pathogenesis, etiology, laboratory diagnosis (review, part 1). Problemy Endokrinologii. 2017;63(4):245–256. (In Russ.) https://doi.org/10.14341/probl2017634245-256.

4. Rayas MS, Salehi M. Non-Diabetic Hypoglycemia. 2024 Jan 27. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E (eds.). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https://pubmed.ncbi.nlm.nih.gov/27099902.

5. Mihai BM, Lăcătuşu CM, Arhire LI, Graur M, Scripcariu V, AniŢei MG et al. Pathological aspects underlying pancreatogenous hyperinsulinemic hypoglycemia – report of three cases. Rom J Morphol Embryol. 2015;56(1):251–256. Available at: https://pubmed.ncbi.nlm.nih.gov/25826512.

6. Laitinen T, Lyyra-Laitinen T, Huopio H, Vauhkonen I, Halonen T, Hartikainen J et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13(2):97–105. https://doi.org/10.1111/j.1542-474X.2008.00208.x.

7. Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract. 2010;16(2):244–248. https://doi.org/10.4158/EP09260.CR.

8. Tsygankova OV, Antipenko AG, Bayramova SS, Molchanova AB, Epifantseva OV. The architectonics of clinical, hormonal and instrumental methods for the diagnosis of insulinoma and the possibility of its treatment. Lechaschi Vrach. 2020;(12):24–29. (In Russ.) https://doi.org/10.26295/OS.2020.49.55.005.

9. Bouslama K, Maghrebi H, Bedioui H, Bouslama K. L´insulinome pancréatique: approche diagnostique et modalités thérapeutiques. J Afr Hepato Gastroenterol. 2014;8(1):11–15. Available at: https://link.springer.com/article/10.1007/s12157-014-0505-9.

10. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab. 2009;94(4):1069–1073. https://doi.org/10.1210/jc.2008-2031.

11. Service FJ. Hypoglycemic disorders. N Engl J Med. 1995;332(17):1144–1152. https://doi.org/10.1056/NEJM199504273321707.

12. Yukina MY, Nuralieva NF, Troshina EA, Kuznetsov NS, Platonova NM. The hypoglicemic syndrome (insulinoma): topical, pathomorphological, and genetic diagnostics and treatment (review, part 2). Problemy Endokrinologii. 2017;63(5):346–355. (In Russ.) https://doi.org/10.14341/probl2017635346-355.

13. Bailey TS, Wallace JF, Pardo S, Warchal-Windham ME, Harrison B, Morin R, Christiansen M. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736-743. https://doi.org/10.1177/1932296816680829.